COMMUNIQUÉS West-GlobeNewswire

Surrozen to Present at Upcoming Healthcare Investor Conference
12/05/2026
SOUTH SAN FRANCISCO, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling [...]
Nurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association Congress
12/05/2026
BRISBANE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]
Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers
12/05/2026
Expansion across the Southeast and Mid-Atlantic includes entry into Pennsylvania through joint venture with University of Pittsburgh Medical Center (UPMC) RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging ( [...]
Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
12/05/2026
Deramiocel BLA under active FDA review; PDUFA target action date of August 22, 2026; labeling discussions expected to commence soon HOPE-3 Phase 3 trial met its primary endpoint (PUL v2.0; upper limb function) and all [...]
Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs
12/05/2026
Data presented at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting SEATTLE, May 12, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible [...]
Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates
12/05/2026
Next anticipated Revita ® clinical data readouts are 1-year data from the REVEAL-1 Cohort in Q2 2026 and 1-year randomized data from the REMAIN-1 Midpoint Cohort in Q3 2026 Early Q4 2026 timing for topline 6-month [...]
Lifecore Biomedical to Participate at CDMO Live Europe
12/05/2026
CHASKA, Minn., May 12, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that [...]
Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference
12/05/2026
WATERTOWN, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that target novel mechanisms [...]
Biomea Fusion to Participate at Upcoming Investor Conferences
12/05/2026
SAN CARLOS, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that management will participate in [...]
Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update
12/05/2026
Topline data from CHAPTER-3, a pivotal Phase 3 study of deucrictibant XR for the prophylaxis of HAE attacks, expected in 3Q2026 Timeline for submission of NDA of deucrictibant IR for the on-demand treatment of HAE [...]
Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
12/05/2026
REDWOOD CITY, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of [...]
Atea Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
12/05/2026
C-BEYOND Phase 3 North American Trial for Treatment of Hepatitis C Virus (HCV) Remains on Track with Topline Results Expected Mid-2026 C-FORWARD Phase 3 Trial Outside North America for Treatment of HCV on Track to [...]
Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference
12/05/2026
SAN JOSE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and [...]
Jushi Holdings Inc. Reports First Quarter 2026 Financial Results
12/05/2026
Revenue of $66.4 million , Up 4% Year-over-Year, Driven by Strong Wholesale Growth and Benefits from Retail Expansion Gross Profit Margin Expanded 460 bps Year-Over-Year to 45.0% , Reflecting Improved Operational [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
12/05/2026
Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
12/05/2026
Nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
12/05/2026
WARREN, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced that it has entered into a securities purchase agreement for a private investment in [...]
Minutes of the General Meeting of 12 May 2026
12/05/2026
Minutes of the General Meeting of 12 May 2026 Paris, 12 May 2026 – The Annual General Meeting of shareholders of Clariane (CLARI - ISIN: FR0010386334) was held on 12 May 2026 (the « General Meeting »), chaired by Sylvia [...]
Compte-rendu de l’Assemblée Générale du 12 Mai 2026
12/05/2026
Compte rendu de l’Assemblée générale du 12 mai 2026 Paris, le 12 mai 2026 – L’Assemblée générale annuelle des actionnaires de la société Clariane (CLARI - ISIN : FR0010386334) s’est réunie le 12 mai 2026 (l’« Assemblée [...]

Pages